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Blood vessel networks expand in a 2-step
process that begins with vessel sprout-
ing and is followed by vessel anastomo-
sis. Vessel sprouting is induced by che-
motactic gradients of the vascular
endothelial growth factor (VEGF), which
stimulates tip cell protrusion. Yet it is not
known which factors promote the fusion
of neighboring tip cells to add new cir-
cuits to the existing vessel network. By
combining the analysis of mouse mu-
tants defective in macrophage develop-
ment or VEGF signaling with live imaging
in zebrafish, we now show that macro-
phages promote tip cell fusion down-
stream of VEGF-mediated tip cell induc-
tion. Macrophages therefore play a
hitherto unidentified and unexpected role
as vascular fusion cells. Moreover, we
show that there are striking molecular
similarities between the pro-angiogenic
tissue macrophages essential for vascu-
lar development and those that promote
the angiogenic switch in cancer, includ-
ing the expression of the cell-surface
proteins TIE2 and NRP1. Our findings
suggest that tissue macrophages are a
target for antiangiogenic therapies, but
that they could equally well be exploited
to stimulate tissue vascularization in
ischemic disease. (Blood. 2010;116(5):
829-840)
Introduction
Blood vessels are essential for tissue homeostasis in all vertebrates,
and new vessel growth, termed neo-angiogenesis, is therefore a
critical process in wound repair to counter tissue ischemia.
Undesirably, neo-angiogenesis also promotes the expansion of
tumors. Moreover, nonproductive neo-angiogenesis, which fails to
restore oxygenation of ischemic tissues, promotes disease progres-
sion in, for example, diabetic retinopathy. Much current research is
therefore focused on the identification of molecular and cellular
targets for either pro- or antiangiogenic therapies. We previously
elucidated the mechanism by which alternative splice forms of
the vascular endothelial growth factor (VEGF) cooperate to
promote blood vessel growth.1,2 This work led to the current
model of angiogenesis, in which blood vessel endothelium
specializes into tip and stalk cells to promote vascular network
expansion by sprouting growth. While the stalk cells form a
lumen to transport blood, the tip cells extend filopodia to detect
chemotactic growth factor gradients, which are formed by a
combination of VEGF isoforms with a differential affinity for
the extracellular matrix. Cooperating with VEGF, notch-delta
signaling controls the balance of tip versus stalk cell specializa-
tion.3 Even though much progress has been made in elucidating
the mechanism of vascular sprout induction and guidance, a
fundamental yet unanswered problem is which mechanism
promotes the fusion of nascent vessel sprouts to add new circuits
to the existing plexus.
Macrophages promote pathologic angiogenesis in several
diseases. Thus, circulating bone marrow–derived cells differen-
tiate into proangiogenic cells with macrophage characteristics at
adult sites of VEGF expression4 and are recruited to growing
tumors to promote tumor vascularization and therefore progres-
sion.5,6 In several diseases, macrophages are variably detrimen-
tal or beneficial. For example, macrophages contribute to
intra-aortic plaque formation in experimental models of artery
occlusion, but can also promote collateral growth to alleviate
ischemia.7,8 In the retina, tissue-resident and recruited macro-
phage populations have been implicated in developmental and
pathologic angiogenesis.9-12 These contradicting results raise the
possibility that different subpopulations of macrophages exist
whose activity could be selectively targeted for pro- or antiangio-
genic therapies, provided that they are distinguishable at the
molecular and functional level.
Supporting the concept of macrophage diversity, a recent
study demonstrated that a subset of monocytes with a noninflam-
matory profile circulates in the blood of healthy adults and
overlaps phenotypically with the macrophage population that
promotes tumor angiogenesis.13 These monocytes/macrophages
are characterized by expression of 2 transmembrane proteins
essential for angiogenesis, the angiopoietin receptor TIE214 and
the multifunctional NRP1 protein, a receptor for specific class 3
semaphorins and VEGF isoforms that also modulates intercellu-
lar adhesion.15 An antigenically similar population of TIE2-
expressing macrophages (TEMs) exists in the embryo before the
production of monocyte-derived macrophages.13 Yet the mecha-
nistic contribution of these TEMs to physiologic angiogenesis
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has not been explored. We demonstrate here that yolk sac–
derived macrophages expressing TIE2 and NRP1 comprise the
major population of tissue macrophages at the time of brain
vascularization, and that they interact with endothelial tip cells
to promote vascular anastomosis downstream of VEGF-
mediated tip cell formation and sprout induction. Our findings
therefore provide fundamental mechanistic insight into the
control of vessel fusion during angiogenesis and draw surprising
parallels between developmental tissue vascularization and the
angiogenic switch in cancer.
Methods
Animals
We used mice with a knockout mutation for Pu.1 (Sfpi1),16 an
inactivating point mutation in Csf1 (Csf1Op/Op),17,18 a knock-in mutation
abrogating the heparin-binding VEGF isoforms (Vegfa120/120)1; a floxed
Vegfa conditional null allele (Vegfafl/) or a LysmCre or NesCre trans-
gene.19-21 We also used mice carrying a floxed yellow fluorescent protein
(YFP) reporter or diphtheria toxin gene in the Rosa26 locus.22,23 Mice
were mated in the evening, and the morning of vaginal plug formation
was counted as 0.5 days postcoitum (dpc). Embryos from different
litters were stage-matched by comparing facial and limb development.
All animal research was conducted with United Kingdom Home Office
and ethical approval.
To visualize macrophages in living zebrafish embryos, we modified a
published construct that expresses green fluorescent protein (GFP)
under the control of the Pu.1 promoter24 to express red fluorescent
protein (RFP; Pu1:Gal4-UAS-TagRFP). Two nanoliters of this construct
together with Tol2 RNA were injected at a final concentration of 25
ng/L each into fertilized Tg(fli1a:EGFP)y5 eggs,25 and eggs were then
incubated at 28°C. For live imaging, embryos were treated with
phenylthiourea at 24 hours postfertilization (hpf) to prevent melaniza-
tion, and at 28 hpf anesthetized in 0.01% tricaine and embedded in 1.5%
low-melting-point agarose. Time-lapse analysis was carried out on a
Leica SPE confocal microscope with a 40 objective with a numerical
aperture (NA) of 0.8 by acquiring z-stacks through the relevant body
region every 3 minutes. The z-stacks were flattened by maximum
projection and arranged in a time series using Volocity software
(Improvision).
Immunolabeling and quantification of vessel and macrophage
density
The following antibodies were used: rat anti–platelet endothelial cell
adhesion molecule (PECAM) and anti-CD11b (BD PharMingen), rat
anti-F4/80 (Serotec), rabbit anti-IBA1 (WAKO), anti-GFP (MBL),
anti–collagen IV (Serotec) or anti–activated caspase 3 (Millipore), goat
anti–rat NRP1 (R&D Systems) or anti–mouse TIE2 (R&D Systems) and
mouse anti– smooth muscle actin (Sigma-Aldrich), Alexa-conjugated
goat anti–rat or anti–rabbit IgG (Molecular Probes) and Cy3-conjugated
rabbit anti–goat Fab fragment (Jackson Immuno). In some experiments,
anti-PECAM was detected by horseradish peroxidase (HRP)–conju-
gated rabbit anti–rat IgG (DAKO), and biotinylated isolectin B4 (IB4;
Sigma-Aldrich) by Alexa-conjugated streptavidin (Molecular Probes) or
streptavidin-HRP (DAKO). Samples were imaged with a Zeiss LSM510
laser scanning confocal microscope or a Leica MZ16 stereomicroscope
equipped with a ProgRes C14 digital camera (Jenoptiks). The following
objectives were used on the LSM510 microscope: 10, NA 0.3; 20,
NA 0.5; 40, NA 1.3; 63, NA 1.4. Images were processed with Adobe
Photoshop CS3 (Adobe Inc). Three-dimensional surface rendering of
high-resolution confocal z-stacks was carried out with Volocity (Impro-
vision). The number of intersections, tip cells, radial vessels and
macrophages in hindbrains, or intersections and regression profiles in
the retina were determined in 3 randomly chosen regions (0.2 mm2 for
confocal, 0.25 mm2 for bright-field images of hindbrains, and 0.05 mm2
for retinal samples). For each genotype or time point, we determined the
mean of 3 to 10 independent samples; error bars represent the standard
deviation of the mean. To determine whether 2 datasets were signifi-
cantly different, we calculated the P value by performing a 2-tailed
unpaired t test; in experiments comparing 3 datasets, we additionally
performed a 1-way ANOVA followed by a Tukey post-hoc test.
Statistical significance is reported in the figures (*P  .05; **P  .01;
***P  .001).
RT-PCR
Total RNA was extracted with Tri-Reagent (Sigma-Aldrich), and contami-
nating DNA was removed with RNase-free DNase (Promega). First-strand
cDNA was synthesized with Superscript Reverse Transcriptase II (Invitro-
gen). RT-PCR was performed with the following oligonucleotide primers:
Pu.1 5-TACCAACGTCCAATGCATGA-3 and 5-CTCCAAGCCAT-
CAGCTTCTC-3; Csf1 5-ATGGACACCTGAAGGTCCTG-3 and 5-
ATGGAAAGTTCGGACACAGG-3; Actb 5-CTCTTCCAGCCTTCCT-
TCCTG-3 and 5-GAAGCATTTGCGGTGGACGAT-3; pan-Vegfa: 5-
ATGAACTTTCTGCTCTCTTGG-3 and 5-TCACCGCCTTGGCTT-
GTCACA-3. Quantitative real-time PCR was conducted with the Power
SYBR Green PCR Master Mix on a 7900HT Fast Real-Time PCR System
(Applied Biosystems) with the following primers: pan-Vegfa 5-GACTTGT-
GTTGGGAGGAGGA-3 and 5-TCTGGAAGTGAGCCAATGTG-3; Actb
5-TCCAAGTATCCATGAAATAAGTGG-3 and 5-GCAGTACATA-
ATTTACACAGAAGC-3. Negative controls contained RNA template not
subjected to reverse transcription. Data were collected using Sequence
Detector software (SDS version 2.2; Applied Biosystems) and analyzed
using DART-PCR software.26 Vegfa expression was normalized using Actb
as a reference.
Results
Spatiotemporal association between macrophages and
sprouting vessels
In the adult, macrophages originate from bone marrow–resident
hematopoietic stem cells via circulating intermediates known as
monocytes. In contrast, the first embryonic macrophages appear in
the yolk sac well before any other leukocytes, and they differentiate
in a rapid pathway that bypasses the monocytic stage.27-29 These
early macrophages travel from the yolk sac into the embryo proper
before the circulation is established, and they therefore predate the
first monocyte-derived macrophages, which originate in the aorta-
gonad-mesonephros region and liver and enter the brain by
extravasation. We reasoned that the embryonic hindbrain was
ideally suited to study the role of the early, yolk sac–derived
macrophages in angiogenesis, because avian studies had demon-
strated that they colonise the brain by crossing the pial membranes
and roof plate concomitantly with, but independently of, blood
vessels.30,31
Using the dual blood vessel/macrophage marker IB4 in combi-
nation with the macrophage-specific markers F4/80 and IBA1,29,32,33
we confirmed that yolk sac–derived macrophages colonized the
embryonic mouse brain independently of vessels, as reported for
the chick (supplemental Figure 1, available on the Blood Web site;
see the Supplemental Materials link at the top of the online article).
We found that embryonic brain macrophages were always IB4-
positive and that they expressed F4/80 by 11.5 dpc (Figure 1A-E;
supplemental Figure 1). We further observed that they rapidly
established a close association with sprouting vessels in the brain
parenchyma. Thus, macrophages accumulated in the subventricular
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zone (SZ) between 10.0 and 11.5 dpc, when vessels began to sprout
laterally and fused with neighboring vessel branches to form the
subventricular vascular plexus (SVP; Figure 1A-B and supplemen-
tal Figure 1B). Moreover, the number of macrophages in the
SZ peaked at 11.5 dpc, the major phase of vascular networking
(Figure 1B,E,I). Correlating with the time point when the SVP had
become established, the macrophage number in the SZ declined
(compare samples at 11.5 and 12.5 dpc; Figure 1C,F,I). Concomi-
tantly with their decrease in the SZ, macrophages began to
accumulate in the deeper brain layers, and this shift in distribution
correlated with the formation of connections between neighboring
radial vessels from 11.5 dpc onwards (compare Figure 1B with
Figure 1C).
During all phases of vascular networking, macrophages
appeared to interact with endothelial tip cells (Figure 1G-H). In
some instances, macrophages bridged neighboring tip cells, as if
to align them in preparation for fusion (Figures 1G and 2A). As
the SVP became more complex, macrophages often localized to
vessel junctions, where they embraced joining vessel segments
(curved arrows in Figures 1E-F and 2B). Three-dimensional
surface rendering of high-resolution confocal z-stacks of hind-
brains in the main phase of vascular networking illustrated the
interaction of macrophages with filopodia on opposing tip cells
more clearly (Figure 2C,C), and further revealed that macro-
phages remained in contact with vessel junctions for at least
some time after vessel sprouts had fused to form a vascular
intersection (Figure 2D,D). Together, these observations sug-
gest that macrophages adopt strategic positions consistent with a
role in promoting vessel fusion.
Essential role for tissue macrophages in embryonic
angiogenesis
To establish if macrophages play an essential role in vascular
networking, we studied mice carrying a loss-of-function mutation
in the gene encoding the transcription factor PU.1,16 which
regulates the expression of myeloid proteins such as the integrin
CD11b (MAC-1, CD18) and the receptor for the macrophage
colony-stimulating factor CSF1 (M-CSF).34 Loss of PU.1 therefore
severely compromises the development of monocyte-derived mac-
rophages, but mice do not suffer obvious brain abnormalities.16,35
Because it was reported that these mice retain some primitive
“macrophage-like” cells that express the CSF1 receptor,36,37 we
first examined if early tissue macrophages were present in these
mice. We found that mouse embryos lacking PU.1 did not contain
any F4/80- or IBA1-positive tissue macrophages in the head
mesenchyme or hindbrain parenchyma at 11.5 dpc (supplemental
Figure 2). This observation confirmed that PU.1 is a master
regulator for the differentiation of both monocyte- and yolk
sac–derived macrophages.
The analysis of Pu.1-null hindbrains revealed that macro-
phage deficiency significantly reduced the number of vessel
intersections and thereby decreased SVP complexity (compare
Figure 3A with B; Figure 3D). Fewer connections also formed
between neighboring radial vessels in mutant compared with
wild-type hindbrains at the time when vascular networking was
initiated in deeper brain layers (compare Figure 3I with J; Figure
3L). These findings suggest that early tissue macrophages play
an essential role in brain angiogenesis. However, the SVP defect
of PU.1 knockouts was less severe than that of Vegfa120/120
Figure 1. Spatiotemporal relationship of tissue macrophages and
blood vessels during angiogenesis in the developing hindbrain.
Eighty-micron transverse sections (A-C) and whole mounts (D-H) of 10.5-,
11.5-, and 12.5-dpc wild-type hindbrains, labeled for IB4 (red) and F4/80
(green). Solid white arrows indicate macrophages positive for both
markers; clear arrows, macrophages positive for IB4 only; curved arrows,
macrophages embracing vascular intersections; arrowheads indicate
endothelial tip cells. (G-H) Higher magnifications of the SVP illustrate the
interaction of tip cells (arrowheads) with macrophages (arrows) and the
bridging of neighboring tip cells by a macrophage (wavy arrow in G; note
that one of the 2 vessel sprouts emerges from a deeper plane of section);
panel H shows a higher magnification of the boxed area in panel E. Scale
bars: panels A through F, 100 m; panels G and H, 25 m. V indicates
ventricular brain surface; p, pial brain surface; rv, radial vessels; hb,
hindbrain; SVP, subventricular vascular plexus; and PNP, perineural
vascular plexus. (I) Quantitation of macrophages (M, green) and vascular
intersections in the SVP (red) between 10.5 and 12.5 dpc; n  15. Error
bars represent SD of the mean.
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mutants, which lack the heparin-binding VEGF isoforms
VEGF164 and VEGF188 and are therefore defective in forming
chemoattractive VEGF gradients for vessel sprouting and guid-
ance1 (compare Figure 3B with C; Figure 3D).
The detailed comparison of the different stages of hindbrain
vascularization suggested that the vascular defects in both types
of mutants arose by a different mechanism. First, vessel
sprouting from the perineural plexus into the brain was strongly
reduced in Vegfa120/120, but not in Pu.1-null mutants (compare
Figure 3E with F-G; Figure 3H). Second, radial vessels had
hardly sprouted laterally in the deeper layers of Vegfa120/120
hindbrains at 12.5 dpc (Figure 3K), but such sprouts were
present in macrophage-deficient brains (Figure 3J). Third,
Vegfa120/120 hindbrains contained significantly fewer tip cells
(Figure 3O), as previously reported,1 but the number and
morphology of tip cells appeared normal in Pu.1-null hindbrains
(Figure 3N,P). Thus, the reduced vascular complexity of
Vegfa120/120 hindbrains is due to a cumulative reduction of vessel
sprouting, which occurs initially at the level of sprout invasion
into the brain (Figure 3G), then at the level of sprouting within
the SZ (Figure 3C,O) and finally at the level of sprouting in the
deeper layers (Figure 3K). Even though there were significantly
fewer tip cells in Vegfa120/120 hindbrains, macrophages still
interacted with the few tip cells that were present (Figure 3O;
see also Figure 5D). In contrast, Pu.1-null mutants did not
appear defective in tip cell induction or sprouting, but specifi-
cally in vascular anastomosis. Therefore, it seems likely that
vascular anastomosis is reduced in Vegfa120/120 mutants because
fewer tip cells are available for fusion, while vascular anastomo-
sis in Pu.1-null mutants is reduced, because macrophages do not
align tip cells in preparation for fusion.
The recruitment of proangiogenic brain macrophages requires
CSF1
Because PU.1-deficient mice are defective in B-cell develop-
ment in addition to macrophage differentiation, we comple-
mented our study by analyzing mice that carry an inactivating
mutation in the Csf1 gene (Csf1Op/Op).17 This mutation impairs
the production of monocyte-derived macrophages, but, unlike
the Pu.1-null mutation, does not impair B-cell development or
T cell–mediated immunity.38 We found that CSF1 deficiency
decreased, but did not abolish the formation of embryonic tissue
macrophages (supplemental Figure 3A-B). However, CSF1
deficiency severely disrupted the recruitment of macrophages
from the head mesenchyme into the brain (supplemental Figure
3A-D). Because Csf1 was expressed in the hindbrain at the time
of macrophage recruitment (supplemental Figure 3F) and CSF1
is a known chemoattractant for macrophages in vitro,39 CSF1
likely mediates the recruitment of proangiogenic macrophages
into the developing brain. Consistent with this idea, CSF1-
deficient hindbrains had an SVP with reduced complexity,
similar to Pu.1-null mice (supplemental Figure 3B-E).
Monocyte-derived macrophages are not essential for
embryonic angiogenesis
Loss of PU.1 or CSF1 also perturbs the production of monocyte-
derived macrophages, which differentiate after the onset of liver
hematopoiesis at 10.5 dpc and may enter the brain by extravasation,
once perfused vessel circuits have been established. To address
whether monocyte-derived macrophages also contributed to vascu-
lar networking, we took advantage of a tool that selectively targets
these cells, a knock-in mouse containing a Cre transgene in the
endogenous Lysm locus (LysmCre)20 that is expressed only after the
onset of liver hematopoiesis.36 A YFP reporter that monitors
CRE-mediated recombination (Rosa26YFP)22 demonstrated that
LysmCre effectively targeted circulating monocytes in the embry-
onic brain (supplemental Figure 4B). In contrast, this promoter was
active in very few tissue macrophages during the time of SVP
formation (supplemental Figure 4C-D). When we eliminated
monocyte-derived macrophages by activating LysmCre-mediated
diphtheria toxin expression from the floxed Rosa26 locus
(Rosa26DTA),23 tissue macrophages were spared, and the SVP
reached normal complexity (supplemental Figure 4E-G). This
finding demonstrated that yolk sac–derived tissue macrophages,
not macrophages derived from circulating monocytes, promote
brain angiogenesis.
Figure 2. Tissue macrophages bridge endothelial tip cells and are present at
vascular junctions. Hindbrains from 11.5- and 12.5-dpc wild-type embryos were
fluorescently labeled with IB4 (red) and F4/80 (green) to reveal the relationship of
endothelial cells (red) and macrophages (double-positive, yellow) in the subventricu-
lar zone. (A) A macrophage (arrow) interacts with the filopodia of 2 opposing tip cells
(arrowheads) at E11.5. (B) A macrophage embraces a 3-way junction, the product of
vessel fusion (curved arrow). (C-D) Snapshots of 3-dimensional models obtained by
surface rendering of the confocal z-stacks shown in panels A and B. Panels C and D
show different angles of the models shown in panels C and D, respectively. Scale bar
represents 25 m.
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Macrophages promote brain angiogenesis independently of
VEGF
Because VEGF functions as a macrophage chemoattractant in
vitro,40 we next asked if it contributed to the recruitment of
angiogenic macrophages, as observed for CSF1 (supplemental
Figure 3). In the developing brain, a combination of both heparin-
and non–heparin-binding VEGF isoforms is normally expressed by
neural progenitors in the SZ, and reducing the expression of all
VEGF isoforms in these cells by targeting one Vegfa allele curbs
vessel sprouting into the brain.41,42 Because the targeting of both
Vegfa alleles with NesCre-mediated CRE/LOX recombination causes
lethality before brain vascularization due to transgene activity early
in embryogenesis,41 we disrupted only one Vegfa allele with NesCre
to examine if reducing VEGF levels in the SZ inhibited the
corecruitment of pro-angiogenic macrophages and vessel sprouts.
For this experiment, we used a NesCre transgene that is active earlier
in brain development than the one previously used21 and effectively
disrupts the expression of VEGF (supplemental Figure 5).1 Consis-
tent with previous observations,41 the reduction of VEGF expres-
sion by neural progenitors significantly impaired vessel sprouting
(Figure 4). Thus, blood vessels in the SZ of NesCre Vegfa/fl
hindbrains were thin, branched infrequently, and had tip cells that
extended few filopodia (Figure 4B,E,G). In contrast, reducing
VEGF expression did not impair the recruitment of tissue macro-
phages into the SZ (Figure 4B,E,G).
In a complementary approach, we evaluated macrophage
recruitment into Vegfa120/120 hindbrains, which specifically lack
the main chemotactic VEGF isoform for macrophages,
Figure 3. Brain angiogenesis is impaired in the absence of macrophages. Angiogenesis in hindbrains lacking PU.1 (Pu.1/) or heparin-binding VEGF isoforms
(Vegfa120/120) at 12.5 dpc (A-L) and 11.5 dpc (M-P). (A-G) Whole mount view onto the SVP (A-C) or radial vessels (RV) diving into the brain parenchyma (E-G), visualized by
PECAM immunohistochemistry (IHC) in a 0.25-mm2 area. (I-K) Transverse sections (100 m) of IB4-labeled hindbrains show vascular bridges (white arrowheads) between
neighboring radial vessels. (M-O) IB4-positive endothelial tip cells (clear arrowheads) and macrophages (clear arrows) in the whole-mounted SVP. Scale bars represent
100 m (A-K) and 50 m (M-O). (D,H,L,P) Quantitation of the number of vascular intersections in the SVP (D; n 	 5), the number of radial vessels (H; n 	 5), and the number
of vascular bridges between radial vessels (L; n 	 3). Error bars represent SD of the mean. P values were determined by comparing the measurements obtained for both types
of mutants to the control, which contained the measurements obtained for wild-types from both groups.
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VEGF164.40 This mutation disrupted vascularization of the SZ
even more severely than the heterozygous loss of VEGF from
neural progenitors (compare Figure 4B with C; Figure 4G), but
it did not impair macrophage recruitment (Figure 4C,G). Rather,
there was a small, but not statistically significant increase in the
number of macrophages in the lateral edge of the posterior
hindbrain, an area that is hypoxic in mutants due to severe
vascular deficiency (Figure 4G and data not shown). Taken
together, our genetic analyses suggest that CSF1, rather than
VEGF164, appears to be the main chemoattractant that recruits
macrophages into the developing brain.
We next asked whether macrophages provide an important
source of VEGF that complements the neural progenitor–derived
VEGF pool. However, Vegfa levels were not reduced in Pu.1-null
hindbrains (Figure 4H). Moreover, a reporter mouse that monitors
sites of Vegfa expression43 did not highlight any macrophages in the
SZ between 10.5 and 13.5 dpc (A.F., Q.S., and C.R., unpublished
observations, October 2009).1 It therefore appears unlikely that
macrophages contribute to brain angiogenesis by providing an
important source of VEGF. In summary, our evidence points
against a role for VEGF in macrophage-mediated vessel fusion
during developmental angiogenesis.
VEGF-mediated tip cell guidance and macrophage-mediated
sprout fusion are discrete but complementary steps that
ensure proper brain vascularization
Because VEGF was not required for macrophage recruitment
into the angiogenic brain, and embryonic brain macrophages did
not make an obvious contribution to the angiogenic VEGF pool,
we hypothesized that VEGF-mediated sprout induction and
macrophage-mediated sprout fusion are separate but complemen-
tary steps during brain angiogenesis. To test this idea, we
generated mutants defective in both processes by mating
heterozygous Vegfa120 and Csf1Op mice to each other and then
interbreeding the double-heterozygous offspring. As predicted,
the compound null mutant offspring of these mice suffered more
severe defects in brain angiogenesis than littermates carrying
solely one type of homozygous mutation (Figure 5). Thus,
Vegfa120/120 Csf1Op/Op double-null mutants contained many en-
larged and blind-ended vessels in the SZ due to the Vegfa120/120
mutation (arrowheads in Figure 5D-E), but, in addition, anasto-
mosis between neighboring vessel units was reduced more
strongly than in single Vegfa120/120 or Csf1Op/Op mutants (com-
pare Figure 5B,D with E).
The great severity of vascular defects in compound mutants
compared with single mutants suggested that an abundance of both
tip cells and macrophages is essential for optimal vascular anasto-
mosis. In further support of this idea, and correlating with the
complete absence of brain macrophages in the Pu.1/ mutants, the
defects of Vegfa120/120 mice carrying the Pu.1-null mutation ap-
peared even more severe than those of Vegfa120/120 mice with the
Csf1Op/Op mutation (compare Figure 5E with Figure 5F). Thus, the
combined disruption of VEGF gradients and macrophage-mediated
vessel fusion reduced the number of vascular intersections in the
SVP significantly more than the disruption of either process alone
(Figure 5G). The finding that the simultaneous loss of heparin-
binding VEGF and macrophages is additive leads us to propose a
model, in which VEGF gradients promote tip cell formation, and
Figure 4. Macrophages promote SVP angiogenesis independently of VEGF.
(A-F) Hindbrains (11.5 dpc) were labeled for IB4 and F4/80; (D-F) higher magnifica-
tions of the boxed areas in (A-C). Controls (no Cre; A,D) were compared with
littermates with a knockdown of VEGF in neural progenitors (NesCreVegfafl/; B,E)
and stage-matched mutants lacking VEGF164 only (Vegfa120/120; C,F). Scale bar
represents 100 m. (G) Quantitation of the number of vascular intersections and
macrophages (M) in the SZ at 11.5 dpc; n 	 3. Error bars represent SD of the mean.
The P values were determined by comparing both types of mutants to Vegfafl/
hindbrains lacking Cre. (H) Quantitation of Vegfa mRNA levels relative to Actb
(
-actin) in PU.1-deficient and wild-type littermate hindbrains at 11.5 dpc. The
horizontal lines indicate the mean; n 	 3.
Figure 5. VEGF-induced vessel sprouting and macrophage-mediated anastomo-
sis act synergistically to promote vascular network formation. (A-F) Morphology
of the SVP (IB4-positive, red) and distribution of tissue macrophages (IB4/F4/80-
double positive, yellow) in 11.5 dpc hindbrains of the indicated genotypes; arrows in
panel D indicate macrophages interacting with endothelial tip cells in Vegfa120/120
mutants; arrowheads in panels D through F denote examples of bulbous vessel ends,
typical of Vegfa120/120 mutants. Scale bar represents 100 m. (G) Quantitation of the
number of vascular intersections in the SZ of the indicated genotypes at 11.5 dpc;
n  3. Error bars represent SD of the mean. (H) Schematic illustration of the role of
macrophages during hindbrain vascularization.
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macrophages act subsequently on these VEGF-induced tip cells to
promote their anastomosis (Figure 5H).
The macrophages that promote vascular network formation are
antigenically more similar to TEMs than inflammatory
macrophages
TIE2 and NRP1 are 2 genes recently found to be significantly
up-regulated in proangiogenic, but not inflammatory tumor macro-
phages.13 To address if the tissue macrophages we identified as
promoters of developmental angiogenesis are functionally related
to the TIE2-expressing macrophages known as TEMs, we immuno-
labeled embryonic hindbrain tissue with antibodies specific for
NRP1 and TIE2 (Figure 6). As expected, but not shown before, we
found that NRP1 was expressed in both endothelial stalk cells and
tip cells, where it was particularly prominent on tip cell filopodia
(Figure 6A-F). In addition, NRP1 was expressed on the surface of
the majority of tissue macrophages (arrows in Figure 6A-E) and
neural progenitors (Figure 6G). The specificity of the antibody used
was established by staining of Nrp1-null hindbrain tissue; thus, the
endothelial cells in the few abnormal vessels typical of these
mutants were labeled by IB4, but not by the NRP1 antibody, and
the same was true for tissue macrophages (Figure 6H-I). Similar to
NRP1, TIE2 was coexpressed in endothelial cells and tissue
macrophages during sprouting angiogenesis in the brain (Figure
6J-K). Even though TIE2 expression was heterogeneous within the
vasculature, TIE2 levels appeared to be particularly high in some
nascent sprouts and their interacting macrophages. In contrast, the
proangiogenic embryonic tissue macrophages do not appear to
express FLT1/VEGFR1 (data not shown), even though this VEGF
receptor is a marker for bone marrow–derived macrophages that
promote pathologic angiogenesis.44
Macrophages in vascular patterning during perinatal
angiogenesis
To provide evidence that macrophages play a role in vascular
network formation beyond early embryogenesis, we studied a
second widely used angiogenesis model, the postnatal mouse
retina. Like the brain, the eye is invaded by yolk sac–derived
macrophages during embryogenesis (Figure 7A). Macrophage
colonization of the retina therefore takes place long before its
vascularization, which begins at birth, when vessel sprouts
emerge from the optic nerve head and spread perpendicularly
over the surface of the retina; further sprouting is then directed
downwards into the inner layers of the retina, where sprouts fuse
Figure 6. TEM antigen expression by proangiogenic hindbrain macrophages. (A-B) Wild-type hindbrains (11.5 dpc) were double-labeled for IB4 and NRP1 to
visualize the subventricular zone, including the SVP; the boxed areas in panels A, A, and A are shown in higher magnifications in panels B, B, and B, respectively;
yellow indicates colocalization in panels A and B. Many NRP1-positive macrophages (arrows in B,B) interacted with endothelial tip cells (arrowheads in panel B);
a NRP1-positive macrophage bridging neighboring tip cells is indicated with a wavy arrow in panels B and B. (C-G) Double labeling for NRP1 and the macrophage
markers CD11b (CD18/MAC-1), F4/80, or IBA1 (C-E), the vascular endothelial marker PECAM (F), or the neural progenitor marker SOX2 (G) established that NRP1
was expressed in all 3 cell types. Yellow indicates coexpression of NRP1 with macrophage and endothelial markers on the cell surface; in contrast, NRP1 surrounds the
SOX2-positive neural progenitor nuclei. The images shown in panels F and G are stacks through the SVP or neural progenitor layer only. (H-I) The specificity of the
NRP1 antibody was established by immunolabeling a Nrp1-deficient hindbrain, obtained from a littermate embryo of the wild-type shown in panels A and B. (J-K) Like
NRP1, TIE2 (red) colocalized with IB4 (green) on a filopodia-bearing endothelial tip cell (arrowhead) and interacting tissue macrophage (arrow). Scale bars represent
25 m (except A-A, 100 m).
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to form the intermediate plexus around the second week after
birth and then the deep vascular plexus in the third week (Figure
7B).45 We observed that endothelial tip cells at the sprouting
front of the retinal vasculature were in close contact with
ramified tissue macrophages (microglia; solid arrows in Figure
7C). Moreover, macrophages bridged neighboring sprouts while
they were anastomosing (wavy arrows in Figure 7C), as
observed in the developing hindbrain (Figures 1-2). The interac-
tion of tissue macrophages and endothelial cells is therefore
similar in the hindbrain and retina, even though retinal macro-
phages appeared morphologically more differentiated.
A recently published study reported that Csf1Op/Op mice form a
superficial retinal plexus that is less complex than that of wild-
types on postnatal day (P) 4, but that vascular density was normal at
3 weeks of age.9 Because macrophages control endothelial cell
death during the natural regression of the hyaloid arteries,46 we
asked if normalization of the retinal vasculature in Csf1Op/Op
mutants was due to reduced remodeling. We found that regressing
vessels in the superficial plexus of the wild-type retina could be
identified by the presence of activated caspase 3 (Figure 7E), but
also morphologically by their reduced diameter. Thus, vessel
segments began to narrow first at the junction with other vessels
(clear arrowheads in Figure 7E) and subsequently became thin,
acellular capillaries that retained collagen IV and IB4 (feathered
arrows in Figure 7F). As expected, macrophages were often
associated with regressing vessels (arrow in Figure 7E). At P9,
regressing vessel segments were prominent near arteries, where
capillary-free spaces arise (Figure 7D-F).45 Similar regression
profiles were found in the wild-type intermediate plexus at P14 (not
shown) and in the deep plexus at P21 (Figure 7G).
Because the deep plexus forms the more extensive and homoge-
neous capillary bed of the 3 retinal vessel networks, we compared
remodeling in macrophage-deficient and normal mice in this
vascular bed (Figure 7G-J). We found that the deep plexus of
Csf1Op/Op mutants and their wild-type littermates contained a
similar number of intersections between stable, lumenized microves-
sels of regular diameter (Figure 7J; compare Figure 7G with Figure
7H); however, the number of regressing, acellular capillaries was
significantly lower in Csf1Op/Op mutant eyes (Figure 7K; compare
Figure 7G with H). We obtained similar results when we examined
the deep plexus of PU.1-deficient mice, which had survived the
perinatal period with a small number of macrophages (Figure 7I-K;
3/12 Pu.1-null neonates from 8 litters containing a total of 41 pups
on the C57/Bl6 background were alive at P21 with incisor defects
similar to Csf1Op/Op mice, but no other gross anatomical deficien-
cies). Together, these results suggest that a reduced number of
Figure 7. Retinal angiogenesis is impaired in the absence of tissue macrophages. Double-labeling of transverse sections through a wild-type mouse eye at 11.5 dpc
(A) and a wild-type mouse retina at P21 (B) with IB4 and F4/80 (A) or an antibody specific for smooth muscle actin (SMA); cell nuclei in panel B were labeled with DAPI.
(C-I) Whole mount labeling of the wild-type retinal vasculature at P4 (C), P9 (D-F) and P21 (G-I). (C) Some macrophages (solid arrows) interact with endothelial tip cells (solid
arrowheads) at the vascular front; others embrace emerging vascular bridges (wavy arrows). (D-E) Activated caspase 3 (aC3) is present in regressing vessel segments near
arteries (yellow); note capillary narrowing at the junction of the regressing vessel segment with a stable vessel (open arrowheads) and a macrophage at one of the narrow ends
(solid arrow); the area boxed in panel D is shown at higher magnification in panel E. (F) Collagen IV and IB4 expression are retained by acellular capillaries (feathered arrow).
(G-I) IB4-positive vessel regression profiles (red arrows) and stable intersections (red arrowheads) between nonregressing vessel segments at P21 in the deep plexus of the
indicated genotypes. Scale bars represent 50 m (except in A, 100 m). (J-K) Quantitation of stable intersections (J) and regression profiles (K) in the deep plexus at P21;
n 	 3. Error bars represent SD of the mean. P values were determined by comparing the measurements obtained for both types of mutants to the control, which contained the
measurements obtained for wild-types from both groups. SP indicates superficial plexus; IP, intermediate plexus; DP, deep plexus; ONL, outer nuclear layer; INL, inner nuclear
layer; RGC, retinal ganglion cell layer; OPL, outer plexiform layer; PR, photoreceptor layer; a, artery; and v, vein.
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vessel intersections in macrophage-deficient mice at early stages of
retinal development were balanced by a compensatory decrease in
vessel pruning at later stages, and that the developing vasculature
therefore becomes normalized by an adaptation of vascular
remodeling.
Live imaging in zebrafish confirms a role for tissue
macrophages in developmental angiogenesis
The morphologic and genetic data described above support a role
for tissue macrophages in vascular anastomosis. To directly
visualize the behavior of macrophages during vessel fusion and
extend our findings to another model organism, we performed live
imaging of vascular fusion sites in the developing zebrafish. To
identify tissue macrophages, we modified a previously published
DNA construct24 to express RFP under the control of the macro-
phage Pu.1 promoter and injected it into zebrafish embryos
containing green fluorescent blood vessels.25 We then imaged the
process by which bilateral intersomitic blood vessels grow dorsally,
branch laterally and fuse with branches from neighboring inter-
somitic vessels to form the dorsal longitudinal anastomotic vessel
(DLAV) on each side of the trunk.47 We observed that tissue
macrophages migrated to sites of vessel fusion, where they
interacted with endothelial cells (Figure 8, showing individual
frames from supplemental Video 1). Figure 8A shows a macro-
phage that migrated toward a site of imminent anastomosis, where
it changed direction to spread laterally and contact opposing tip
cells (macrophage no. 1); the macrophage remained associated
with both tip cells during the process of vessel fusion. Figure 8B
shows an adjacent field of the same video, where another macro-
phage (no. 2) interacted with 2 vessel segments that were tran-
siently severed during an endothelial cell mitosis. Thus, as the
dividing cell in the DLAV (clear arrowhead) lost contact with the
adjacent intersomitic vessel (arrowhead), this macrophage bridged
the vascular gap until both vessel segments were reconnected
(forked arrowhead). Figure 8B also shows another macrophage
(no. 3), which extended processes to dynamically interact with tip
cell filopodia in the youngest part of this region (wavy arrow).
These findings establish that macrophages interact with endothelial
tip cells during vascular anastomosis in the zebrafish trunk.
Moreover, they suggest that tissue macrophages are important for
angiogenesis in several vascular beds and across different verte-
brate species.
Discussion
Even though several subsets of macrophages have been implicated
in pathologic angiogenesis, little attention has so far been paid to
the significance of macrophage heterogeneity for physiologic tissue
vascularization. While many types of adult macrophages involved
in pathologic angiogenesis originate from bone marrow–resident
hematopoietic stem cells via circulating monocytes, the first
macrophages differentiate in the embryo without a monocytic
intermediate and persist into adulthood as tissue macrophages.27-30
Yet the role of these early tissue macrophages in embryonic
angiogenesis has not previously been explored. In this report, we
show that they promote vascular networking.
For our studies, we concentrated on the embryonic hindbrain,
because this organ is particularly amenable to the quantitative and
qualitative analysis of angiogenesis, and because it is colonized by
yolk sac–derived macrophages independently of blood vessels
(supplemental Figure 1).31,36,48 These early macrophages give rise
to the self-renewing parenchymal microglia of adults49 and are
distinct from adult perivascular macrophages, which differentiate
from bone marrow–derived monocytic precursors.50 We found
embryonic tissue macrophages in close spatiotemporal association
with sprouting vessels in the brain (supplemental Figure 1; Figures
1-2). Because tissue macrophages are highly motile cells that do
not reside in any particular space for long,51 we were intrigued by
the ease with which we captured their simultaneous interaction
with one or more spatially well-separated tip cells (Figures 1-2,6).
We found that macrophages also associated with endothelial tip
Figure 8. Tissue macrophages interact with endothelial cells at sites of vessel fusion in the developing zebrafish trunk. Series of laser confocal projections extracted
from a time-lapse video (supplemental Video 1) showing the interaction of 3 tissue macrophages (red; 1-3) with blood vessels (green); the time elapsed after starting the video
at 28 hpf is indicated in hours:minutes in the bottom left of each panel; 3 adjacent intersegmental blood vessels are imaged over a period of 4:16. (A) A macrophage (1) migrates
into a region where the tip cell from the caudal sprout of one intersomitic vessel fuses with the tip cell of a rostral sprout of the next intersomitic vessel; arrows indicate the
direction of macrophage migration. (B) A macrophage (2) migrates to a site where a dividing endothelial cell in the forming DLAV (clear arrowhead) transiently loses contact with
the intersomitic vessel (arrowheads); it remains in this position while the connection is re-established (forked arrowheads); yet another macrophage (3) interacts with filopodial
protrusions from opposing tip cells (wavy arrow). Scale bar represents 50 m.
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cells during retinal angiogenesis (Figure 7C) and during vessel
fusion in the zebrafish trunk (Figure 8).
Because our observations further raised the possibility that
macrophages interact with multiple tip cells to bring them into
close apposition for fusion, we next investigated if macrophages
were essential regulators of either tip cell formation or vessel
anastomosis. We found that mice lacking PU.1 or CSF1 were
appropriate models to study the role of macrophages in angiogen-
esis, because PU.1 loss prevented the differentiation of yolk
sac–derived tissue macrophages throughout the embryo, and
CSF1 loss prevented their recruitment from the head mesen-
chyme into the brain parenchyma (supplemental Figures 2-3).
The idea that CSF1, but not VEGF164, is an essential recruit-
ment factor for embryonic macrophages in the mouse brain
(supplemental Figure 3; Figure 4) agrees with observations
made of zebrafish panther mutants, which lack a functional
CSF1 receptor. In these fish, tissue macrophages differentiate
and migrate into the head mesenchyme, but macrophage recruit-
ment into the brain is impaired.48
Having established that PU.1- and CSF1-deficient mice
provided suitable genetic models to uncover essential roles for
tissue macrophages in angiogenesis, we first studied brain
vascularization in these mice. We found that brain vascular
complexity was decreased in both types of mutants (Figures 3,5;
supplemental Figures 2-3). Importantly, the observed defects
were qualitatively and quantitatively different from those of 2
different types of Vegfa mutants (Figures 3-4). Moreover, the
exacerbation of vascular defects in mouse mutants defective in
both VEGF signaling and macrophages (Figure 5) suggested
that the 2 different mutations affect different steps in angiogen-
esis: whereas VEGF is particularly important for vessel sprout-
ing, macrophages act on nascent sprouts to increase vascular
anastomosis (Figure 5H). A similar decrease in vascular complex-
ity was also seen in the retina of perinatal macrophage-deficient
mice (data not shown).9
It is likely that the vascular defect we observed in macrophage-
deficient mice underestimates the true significance of macro-
phages in normal angiogenesis, as is the case for embryonic
footplate limb remodeling. There, macrophages normally clear
the cellular debris that arises from the synchronous apoptosis of
mesenchymal cells in the interdigital regions to facilitate digit
separation; however, neighboring mesenchymal cells substitute
for macrophages in Pu.1-null mutants to clear the apoptotic
debris, although less effectively.52 In analogy, embryos with a
genetic deficiency in tissue macrophages may activate compen-
satory mechanisms to promote vessel fusion. Moreover, emerg-
ing vascular networks appear sufficiently plastic to meet the
physiologic need of the organism, as the overproduction of
microvessels seems to be a normal process that is balanced by
pruning of excess vessel circuits, either because they reside near
arteries or because they are poorly perfused. Thus, we have
shown that the elimination of excess vessel segments is reduced
in macrophage-deficient mice (Figure 7), and we can therefore
now explain why the retinal vasculature of CSF1 mutants, even
though initially of low complexity, ultimately acquires a normal
capillary density.9
Our observation that macrophage-mediated vessel fusion is
most important in circumstances of suboptimal vessel growth
(Figure 5) may explain why macrophage recruitment makes a
significant contribution to pathologic angiogenesis. For ex-
ample, macrophages trigger the angiogenic switch in cancer,
because they help to establish a tumor vasculature, which then
allows tumors to overcome a “bottleneck” for growth that is due
to insufficient oxygen and nutrient supply.5,6 Interestingly, the
proangiogenic tissue macrophages we describe here do not
normally express Lysm (supplemental Figure 4) and do not
provide a significant source of VEGF (Figure 4), 2 features that
distinguish them functionally from one class of VEGF-
secreting, monocyte-derived inflammatory tumor-associated mac-
rophages (TAMs) that promote tumor angiogenesis.53 Instead,
the tissue macrophages we characterize here (Figures 4,6) are
similar to a second class of adult monocyte-derived pro-
angiogenic tumor macrophages known as TEMs, which do not
up-regulate either Vegfa or inflammatory genes, but do express
TIE2 and NRP1.13 Interestingly, macrophages similar to adult
TEMs were also identified in the embryo, but they were not
enriched in the liver, where the first monocyte-derived macro-
phages originate; instead, they were abundant in the mesen-
chyme surrounding developing organs,13 like the proangiogenic
macrophages we have characterized here.
To understand the cellular mechanisms that underlie macro-
phage function in vascular networking, we first investigated if
macrophages stimulated vessel sprouting, but found that this
was not the case (Figure 3). Because macrophages have the
capacity to interact with more than one endothelial tip cell at a
time (Figures 1G, 2A,C, 6C, 7C, and 8), we next considered that
macrophages prime neighboring endothelial tip cells for fusion.
Whereas virtually nothing is known about endothelial fusion in
the vasculature, live imaging of dorsal closure in the Drosophila
larva revealed that filopodia from opposing epithelial sheets
project toward each other and form adhesive tethers, which align
the cells in preparation for fusion.54 In analogy, the filopodia that
extend from tip cells at the front of blood vessel sprouts may
initiate vessel fusion, if they make contact with each other.
However, new vessel sprouts find themselves among a large
number of nonendothelial cells in their host organ, hampering
the process of finding a suitable fusion partner. Tissue macro-
phages, with their great mobility and flexibility and their affinity
for tip-cell filopodia, therefore appear ideally suited to help
endothelial cells on different vessel segments to establish
contact. Consistent with this idea, we observed that tissue
macrophages accumulated at sites of vessel fusion in the living
zebrafish embryo, where they interacted with neighboring tip
cells during the fusion process (Figure 8). Thus, by bridging tip
cells from different vessel segments and embracing nascent
fusion sites, macrophages can act as cellular chaperones for
endothelial cell fusion to increase vascular complexity.
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